Fonar Total Assets 2010-2025 | FONR
Fonar total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Fonar Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $214 |
| 2023 | $201 |
| 2022 | $199 |
| 2021 | $190 |
| 2020 | $180 |
| 2019 | $134 |
| 2018 | $118 |
| 2017 | $99 |
| 2016 | $85 |
| 2015 | $76 |
| 2014 | $77 |
| 2013 | $73 |
| 2012 | $34 |
| 2011 | $32 |
| 2010 | $22 |
| 2009 | $28 |
| Fonar Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $215 |
| 2024-12-31 | $208 |
| 2024-09-30 | $212 |
| 2024-06-30 | $214 |
| 2024-03-31 | $210 |
| 2023-12-31 | $202 |
| 2023-09-30 | $202 |
| 2023-06-30 | $201 |
| 2023-03-31 | $199 |
| 2022-12-31 | $197 |
| 2022-09-30 | $198 |
| 2022-06-30 | $199 |
| 2022-03-31 | $196 |
| 2021-12-31 | $194 |
| 2021-09-30 | $188 |
| 2021-06-30 | $190 |
| 2021-03-31 | $185 |
| 2020-12-31 | $182 |
| 2020-09-30 | $181 |
| 2020-06-30 | $180 |
| 2020-03-31 | $171 |
| 2019-12-31 | $172 |
| 2019-09-30 | $167 |
| 2019-06-30 | $134 |
| 2019-03-31 | $127 |
| 2018-12-31 | $123 |
| 2018-09-30 | $120 |
| 2018-06-30 | $118 |
| 2018-03-31 | $107 |
| 2017-12-31 | $105 |
| 2017-09-30 | $101 |
| 2017-06-30 | $99 |
| 2017-03-31 | $92 |
| 2016-12-31 | $88 |
| 2016-09-30 | $86 |
| 2016-06-30 | $85 |
| 2016-03-31 | $82 |
| 2015-12-31 | $80 |
| 2015-09-30 | $79 |
| 2015-06-30 | $76 |
| 2015-03-31 | $75 |
| 2014-12-31 | $79 |
| 2014-09-30 | $79 |
| 2014-06-30 | $77 |
| 2014-03-31 | $76 |
| 2013-12-31 | $77 |
| 2013-09-30 | $76 |
| 2013-06-30 | $73 |
| 2013-03-31 | $73 |
| 2012-12-31 | $37 |
| 2012-09-30 | $35 |
| 2012-06-30 | $34 |
| 2012-03-31 | $35 |
| 2011-12-31 | $33 |
| 2011-09-30 | $33 |
| 2011-06-30 | $32 |
| 2011-03-31 | $26 |
| 2010-12-31 | $24 |
| 2010-09-30 | $22 |
| 2010-06-30 | $22 |
| 2010-03-31 | $23 |
| 2009-12-31 | $25 |
| 2009-09-30 | $27 |
| 2009-06-30 | $28 |
| 2009-03-31 | $30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.099B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |